Detection and quantification of myocardial scars by contrast-enhanced 3D echocardiography

Circulation: Cardiovascular Imaging

Volumn 3, Issue 4, 2010, Pages 415-423

  Montant, Patrick ^a   Chenot, Fabien ^a   Goffinet, Céline ^a   Poncelet, Alain ^a   Vancraeynest, David ^a   Pasquet, Agnès ^a   Gerber, Bernhard L ^a   Vanoverschelde, Jean Louis J ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Echocardiography; MRI; Myocardial infarction

Indexed keywords

CONTRAST MEDIUM; CONTRAST AGENT BR1; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HUMAN; MALE; NOISE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SCAR; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CICATRIX; CONTRAST MEDIA; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SULFUR HEXAFLUORIDE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77955504089     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.109.912477     Document Type: Article

References (24)

1. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117:103-114.
2. Underwood R, Bax JJ, von Dahl J, Henein MY, Van Rossum AC, Schwartz E, Vanoverschelde JL, van der Wall E, Wijns W. Imaging techniques for the assessment of myocardial hibernation: report of a study group of the European Society of Cardiology. Eur Heart J. 2004;25: 815-836.
3. Vanoverschelde JL, D'Hondt AM, Marwick T, Gerber BL, De Kock M, Dion R, Wijns W, Melin JA. Head-to-head comparison of exerciseredistribution- reinjection thallium single-photon emission computed tomography and low-dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol. 1996;28:432-442.
4. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patient with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-1158.
5. Pasquet A, Robert A, D'Hondt AM, Dion R, Melin J, Vanoverschelde JL. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation. 1999;100: 141-148.
6. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
7. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Bundy J, Klocke FJ, Bonow R, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
8. Hoyt RH, Collins SM, Skorton DJ, Ericksen EE, Conyers D. Assessment of fibrosis in infarcted human hearts by analysis of ultrasonic backscatter. Circulation. 1985;71:740-744.
9. Tabel GM, Whittaker P, Vlachonassios K, Sonowala M, Chandraratna PA. Collagen fiber morphology determines echogenicity of myocardial scar: implications for image interpretation. Echocardiography. 2006;23: 103-107.
10. Rasmussen S, Corya BC, Feigenbaum H, Knoebel SB. Detection of myocardial scar tissue by M-mode echocardiography. Circulation. 1978; 57:230-237.
11. Parisi AF, Nieminen M, O'Boyle JE, Moynihan PF, Khuri SF, Kloner RA, Folland ED, Schoen FJ. Enhanced detection of the evolution of tissue changes after acute myocardial infarction using color-encoded twodimensional echocardiography. Circulation. 1982;66:764-770.
12. Lang RM, Mor-Avi V, Sugeng L, Nieman P, Sahn D. Three-dimensional echocardiography: the benefits of additional dimension. J Am Coll Cardiol. 2006;48:2053-2069.
13. Kühl HP, Schreckenberg M, Rulands D, Katoh M, Schäfer W, Schummers G, Bücker A, Hanrath P, Franke A. High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2004;43:2083-2090.
14. Pouleur A-C, le Polain de Waroux JB, Pasquet A, Gerber BL, Gérard O, Allain P, Vanoverschelde J-L. Assessment of left ventricular mass and volumes by three-dimensional echocardiography in patients with or without wall motion abnormalities: comparison against cine magnetic resonance imaging. Heart. 2008;94:1050-1057.
15. Jenkins C, Moir S, Chan J, Rakhit D, Haluska B, Marwick T. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J. 2009;30:98-106.
16. Lim P, Pasquet A, Gerber B, D'Hondt A-M, Vancraeynest D, Guéret P, Vanoverschelde J-L. Is post-systolic shortening a marker of viability in chronic left ventricular ischemic dysfunction? comparison with late enhancement contrast MRI. J Am Soc Echo. 2008;21:452-457.
17. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim R. Delayed enhancement cardiovascular magnetic resonance assessment of nonischaemic cardiomyopathies. Eur Heart J. 2005;26:1461-1474.
18. Kaandorp TA, Lamb HJ, Van der Wall EE, De Roos A, Bax JJ. Cardiovascular MR to assess myocardial viability in chronic ischemic LV dysfunction. Heart. 2005;91:1359-1365.
19. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101-1107.
20. Gerber BL, Rochitte CE, Bluemke DA, Melin JA, Crosille P, Becker LC, Lima JAC. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation. 2001;104:998-1004.
21. Haluska B, Case C, Short L, Anderson J, Marwick TH. Effect of power Doppler and digital subtraction techniques on the comparison of myocardial contrast echocardiography with SPECT. Heart. 2001;85:549-555.
22. Korosouglou G, Hansen A, Hoffend J, Gavrilovic G, Wolf D, Zehelein J, Haberkorn U, Kuecherer H. Comparison of real-time myocardial contrast echocardiography for the assessment of myocardial viability with fluorodeoxyglucose-18 positron tomography and dobutamine stress echocardiography. Am J Cardiol. 2004;94:570-576.
23. Shimoni S, Frangogiannis NG, Aggeli CJ, Shan K, Verani M, Quinones MA, Espada R, Letsou GV, Lawrie GM, Winters WL, Reardon MJ, Zoghbi WA. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation. 2003;107:538-544.
24. Hayat SA, Senior R. Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time? Eur Heart J. 2008;29:299-314.